Social Media Content Creators Fueling Parallel Market for Unapproved Slimming Medication
An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Treatment Acquiring Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before directing buyers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Voice Concerns
However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could result in individuals injecting substances of unknown origin.
Several professionals stated the demand for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the British medical regulations.
Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.
Service Response and Material Removal
According to TikTok, the platform has taken down violative material and prohibited related hashtags and query recommendations. The company said it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Research also found communities with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, positive testimonials and detailed instructions for mixing or injecting at home.
Within minutes of entering one community, a vendor shared contact information, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.
Item Details and Pricing
Inside these groups, messages display dark colored parcels with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for Telegram stated it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they can’t verify. Even if the science behind this drug is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But fake treatments are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has already seen patients injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to potentially significant health risks”.